)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
MediWound (MDWD) investor relations material
MediWound Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary20 Nov, 2025
Executive summary
Achieved strong execution across strategic, clinical, and operational objectives, positioning for next growth phase.
Achieved Q3 2025 revenue of $5.4 million, up 23% year-over-year, driven by higher development services revenue and new DOD contracts.
Advanced EscharEx VALUE Phase III trial for venous leg ulcers, with most sites now active and enrolling; FDA-aligned trial design and plans to initiate diabetic foot ulcer trial in H2 2026.
Expanded NexoBrid manufacturing facility, increasing production capacity sixfold, with full operational capacity expected by year-end 2025.
Strengthened balance sheet with $30 million equity financing from healthcare investors, supporting development and commercialization initiatives.
Financial highlights
Q3 2025 revenue was $5.4 million (up 23% YoY), driven by higher development services revenue including DOD contracts.
Gross profit for Q3 was $0.9 million (16.5% margin), up from $0.7 million (15.5%) last year.
Q3 net loss was $2.7 million ($0.24/share), a significant improvement from $10.3 million ($0.98/share) in Q3 2024, mainly due to non-cash financial income from warrant revaluation.
Adjusted EBITDA loss for Q3 was $5.4 million, compared to $3.7 million loss last year.
For the first nine months, revenue was $15.1 million (vs. $14.4 million), gross profit $3 million (19.7% margin), net loss $16.7 million ($1.53/share), improved from $26.3 million ($2.72/share) last year.
Outlook and guidance
Monitoring EU regulatory adjustments for EscharEx VLU trial; will update guidance as visibility improves.
Diabetic foot ulcer (DFU) program to initiate in H2 2026, pending EMA feedback and protocol alignment.
Expect full operational capacity at new NexoBrid facility by year-end 2025, with regulatory review determining commercial output timing.
BARDA and DOD-related revenue timing for Q4 uncertain due to recent government shutdown; activities expected to resume.
Market access and pricing assessment estimates peak sales opportunity for EscharEx at $831 million.
Assess EscharEx VLU trial timeline impact from EU sites
BARDA contract status and Q4 revenue impact
NexoBrid permanent CPT code adoption impact
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next MediWound earnings date
Q4 202516 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
MediWound Ltd. specializes in the development, manufacture, and commercialization of innovative therapies for tissue repair and regeneration. The company focuses primarily on enzymatic debridement solutions for the treatment of severe burns, chronic wounds, and other hard-to-heal injuries. MediWound's proprietary technologies are designed to improve the healing process by selectively removing dead or damaged tissue without harming surrounding healthy tissue. The company serves healthcare providers, hospitals, and wound care centers globally, aiming to enhance patient outcomes and reduce treatment costs. MediWound is headquartered in Yavne, Israel, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage